Just recently, the Italian Surgica Robotica S.p.a. company revealed some details about their new system, the Surgenius. "Surgica Robotica has built the first fully functional prototype, Surgenius ALPHA, in 4 months. The prototype has been successfully tested both in-vitro and in-vivo. With the knowledge, the data and the analysis of the technical solutions used in ALPHA, Surgica Robotica spent one year and a half to design, build and tune a new system, Surgenius BETA. The new system has been tested in-vitro and in-vivo. Usability and performance evaluation have been carried out with well known surgeons with extensive experience in robotic surgery. Tasks relevant to robot-assisted surgical procedures have been performed on animals by our surgeons, and they have been successfully completed without the need of any technical intervention on the robot. Surgenius BETA is compliant with the applicable EU regulations." (You can learn more about its history from the previous posts.) The robot received CE mark in March, and now the beta prototype is getting ready for clinical trials.
"The Surgenius BETA surgical robot is the first component of the surgical system under development by Surgica Robotica. It has the capability to perform the common tasks of laparoscopic surgery such as:
- Soft-tissue grabbing
- Soft-tissue cutting
The robot offers excellent performance and reliability with unprecedented flexibility and modularity. The robotic arms can be positioned freely around the surgical bed, as they are independent of each other. They can be equipped with Surgica Robotica's high dexterity instruments, which allow great precision and wide maneuverability. The surgical system can be configured with the number of robotic arms that is necessary for the intervention, from one single arm to as many arms as they fit around the surgical bed.
With high precision and proper scaling, the system can significantly improve the outcome in the surgical procedure, at a cost per procedure that can be accurately tuned."